TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Harrow Health ( (HROW) ) just unveiled an update.
On September 26, 2025, Harrow, Inc. entered into a New Credit Agreement with Fifth Third Bank for a senior secured revolving credit facility of $40 million, with an additional uncommitted $20 million line of credit. The agreement, maturing in 2030, includes covenants and financial requirements, impacting Harrow’s financial operations and strategic flexibility.
The most recent analyst rating on (HROW) stock is a Buy with a $63.00 price target. To see the full list of analyst forecasts on Harrow Health stock, see the HROW Stock Forecast page.
Spark’s Take on HROW Stock
According to Spark, TipRanks’ AI Analyst, HROW is a Neutral.
Harrow Health’s overall stock score is driven by strong earnings call results and positive technical indicators, indicating growth potential. However, significant financial performance challenges and valuation concerns weigh heavily on the score. Addressing cash flow issues and improving profitability are crucial for enhancing financial stability.
To see Spark’s full report on HROW stock, click here.
More about Harrow Health
Average Trading Volume: 582,498
Technical Sentiment Signal: Strong Buy
Current Market Cap: $1.74B
For an in-depth examination of HROW stock, go to TipRanks’ Overview page.